FLNA Filana Therapeutics Inc

Price (delayed)

$0.8701

Market cap

$42.03M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.87

Enterprise value

-$40.65M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 12
Highlights
Filana Therapeutics's EPS has soared by 66% YoY and by 46% from the previous quarter
The net income has soared by 66% YoY and by 46% from the previous quarter
Filana Therapeutics's equity has decreased by 28% YoY and by 7% from the previous quarter
The quick ratio is down by 13% year-on-year and by 4.6% since the previous quarter

Key stats

What are the main financial stats of FLNA

FLNA stock price

How has the Filana Therapeutics stock price performed over time
Intraday
-15.52%
1 week
27.17%
1 month
-9.46%
1 year
N/A
YTD
N/A
QTD
-26.88%

Financial performance

How have Filana Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$45.97M
Net income
-$42.28M
Gross margin
N/A
Net margin
N/A
The net income has soared by 66% YoY and by 46% from the previous quarter
Filana Therapeutics's operating income has soared by 65% YoY and by 44% from the previous quarter

Price vs fundamentals

How does FLNA's price correlate with its fundamentals

Growth

What is Filana Therapeutics's growth rate over time

Valuation

What is Filana Therapeutics stock price valuation
P/E
N/A
P/B
0.66
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Filana Therapeutics's EPS has soared by 66% YoY and by 46% from the previous quarter
FLNA's P/B is 83% below its 5-year quarterly average of 4.7 and 40% below its last 4 quarters average of 1.3
Filana Therapeutics's equity has decreased by 28% YoY and by 7% from the previous quarter

Efficiency

How efficient is Filana Therapeutics business performance
Filana Therapeutics's ROA has soared by 51% YoY and by 42% from the previous quarter
FLNA's return on equity is up by 41% since the previous quarter and by 37% year-on-year

Dividends

What is FLNA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FLNA.

Financial health

How did Filana Therapeutics financials performed over time
The total assets is 158% more than the total liabilities
The total assets has decreased by 23% YoY and by 4.1% from the previous quarter
FLNA's total liabilities is down by 15% YoY
Filana Therapeutics's debt is 100% less than its equity
Filana Therapeutics's equity has decreased by 28% YoY and by 7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.